We are live on
!
Find out more
MIM
MetLife Investment Management Portfolio holdings
AUM
$19.6B
1-Year Est. Return
32.64%
This Fund
S&P 500
This Quarter
Est. Return
+15.44%
1 Year Est. Return
+32.64%
3 Year Est. Return
+107.14%
5 Year Est. Return
+140.16%
10 Year Est. Return
–
AUM
$17B
AUM Growth
-$1.5B
(-8.1%)
Cap. Flow
-$3.24B
Cap. Flow
% of AUM
-19.02%
Top 10 Holdings %
Top 10 Hldgs %
26.33%
Holding
2,961
New
180
Increased
949
Reduced
1,091
Closed
240
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Coeur Mining
CDE
|
+$20.8M |
| 2 |
Atlantic Union Bankshares
AUB
|
+$16.7M |
| 3 |
Lincoln National
LNC
|
+$14.7M |
| 4 |
JBTM
JBT Marel
JBTM
|
+$13.3M |
| 5 |
Yeti Holdings
YETI
|
+$12.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$997M |
| 2 |
Amazon
AMZN
|
+$539M |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$276M |
| 4 |
Berkshire Hathaway Class B
BRK.B
|
+$254M |
| 5 |
Bank of America
BAC
|
+$71.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 27.35% |
| 2 | Financials | 13.45% |
| 3 | Industrials | 10.46% |
| 4 | Healthcare | 10.18% |
| 5 | Communication Services | 9.05% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2001
Vir Biotechnology
VIR
$1.52B
| $275K | ﹤0.01% |
54,480
| – | – |
|
2002
Arbutus Biopharma
ABUS
$906M
| $274K | ﹤0.01% |
88,766
-121
| -0.1% | -$402 |
|
|
XRN
2003
Chiron Real Estate Inc
XRN
$484M
| $274K | ﹤0.01% |
7,904
+703
| +10% | +$24.5K |
|
2004
South Plains Financial
SPFI
$859M
| $273K | ﹤0.01% |
7,570
+964
| +15% | +$33.2K |
|
2005
Ginkgo Bioworks
DNA
$488M
| $273K | ﹤0.01% |
+24,247
| New | +$188K |
|
2006
Mesa Laboratories
MLAB
$633M
| $272K | ﹤0.01% |
2,888
| – | – |
|
|
FSUN
2007
FirstSun Capital Bancorp
FSUN
$2.02B
| $271K | ﹤0.01% |
+7,809
| New | +$273K |
|
2008
Stoke Therapeutics
STOK
$2.02B
| $271K | ﹤0.01% |
23,863
+3,609
| +18% | +$34.3K |
|
2009
LendingTree
TREE
$461M
| $270K | ﹤0.01% |
7,289
+1,354
| +23% | +$54.7K |
|
|
FFIC
2010
DELISTED
Flushing Financial
FFIC
| $269K | ﹤0.01% |
22,634
+5,975
| +36% | +$72K |
|
2011
York Water
YORW
$536M
| $268K | ﹤0.01% |
8,495
| – | – |
|
2012
Mitek Systems
MITK
$853M
| $267K | ﹤0.01% |
27,018
+4,192
| +18% | +$37.6K |
|
2013
FerroAtlántica
GSM
$818M
| $267K | ﹤0.01% |
+72,803
| New | +$267K |
|
2014
NerdWallet
NRDS
$639M
| $266K | ﹤0.01% |
24,273
+367
| +2% | +$3.68K |
|
2015
Wabash National
WNC
$509M
| $266K | ﹤0.01% |
24,999
-476
| -2% | -$4.58K |
|
2016
Celcuity
CELC
$4.22B
| $265K | ﹤0.01% |
19,872
| – | – |
|
|
NUTX
2017
Nutex Health
NUTX
$1.28B
| $265K | ﹤0.01% |
+2,129
| New | +$275K |
|
|
BORR
2018
Borr Drilling
BORR
$1.25B
| $264K | ﹤0.01% |
144,409
| – | – |
|
2019
Monro
MNRO
$352M
| $264K | ﹤0.01% |
17,704
| – | – |
|
2020
Aspen Aerogels
ASPN
$504M
| $264K | ﹤0.01% |
44,577
-719,846
| -94% | -$4.14M |
|
2021
SentinelOne
S
$8.17B
| $264K | ﹤0.01% |
14,426
+7,358
| +104% | +$135K |
|
2022
Keros Therapeutics
KROS
$211M
| $264K | ﹤0.01% |
19,749
+1,651
| +9% | +$22.3K |
|
|
NFBK
2023
DELISTED
Northfield Bancorp
NFBK
| $263K | ﹤0.01% |
22,946
+1,843
| +9% | +$20.5K |
|
2024
Third Coast Bancshares
TCBX
$766M
| $263K | ﹤0.01% |
8,037
| – | – |
|
2025
Dianthus Therapeutics
DNTH
$6.13B
| $263K | ﹤0.01% |
14,093
| – | – |
|
Similar funds
PCM
HHII
EIM
P
BPA
NAM
MIC
MetLife Investment Management's Q2 2025 Portfolio in Review
As of Q2 2025, MetLife Investment Management held 2,961 positions worth $17B, down 8.1% from $18.5B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
MetLife Investment Management withdrew a net $3.24B in Q2 2025, closing 240 positions and reducing 1,091 holdings. Its most notable exit was Apple, an estimated $997M position sold in full.
By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 26% a quarter earlier, followed by Financials and Industrials.
Against the trend, MetLife Investment Management opened a new position in Amrize Ltd worth $2.51M.
- MetLife Investment Management's largest Q2 2025 buy was Amrize Ltd: 50,407 shares worth $2.51M.
- MetLife Investment Management added most to Coeur Mining in Q2 2025, an estimated $20.8M increase.
- MetLife Investment Management's biggest Q2 2025 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $276M.
- MetLife Investment Management fully exited Apple in Q2 2025, selling an estimated $997M.
- MetLife Investment Management's ten largest holdings make up 26% of its $17B portfolio in Q2 2025.
- MetLife Investment Management opened 180 new positions and closed 240 in Q2 2025.
- MetLife Investment Management's portfolio value fell 8.1% quarter-over-quarter to $17B.
Based on MetLife Investment Management's 13F filing for Q2 2025, filed 13 Aug 2025.